Handok Pharmaceuticals’ CEO and Chairman Young-Jin Kim was awarded the 2010 Asia Pacific Frost & Sullivan Diabetes Therapeutics Company of the Year Award by the global research firm, Frost & Sullivan. This award is presented to the top company in the Asia Pacific region working in the diabetes area, and is based on an evaluation of growth strategy and execution, innovative business processes, customer value, and market leadership.